Aspirin therapy reduces the ability of platelets to promote colon and pancreatic cancer cell proliferation: Implications for the oncoprotein c-MYC.
about
Aspirin inhibits the SHH/GLI1 signaling pathway and sensitizes malignant glioma cells to temozolomide therapy.Aspirin regulation of c-myc and cyclinD1 proteins to overcome tamoxifen resistance in estrogen receptor-positive breast cancer cells.Prevention and treatment of cancer targeting chronic inflammation: research progress, potential agents, clinical studies and mechanisms.Platelets, circulating tumor cells, and the circulome.The influence of platelet membranes on tumour cell behaviour.Targeting Platelets for the Treatment of Cancer.Antiplatelet agents for cancer treatment: a real perspective or just an echo from the past?Acetylsalicylic acid inhibits the growth of melanoma tumors via SOX2-dependent-PAF-R-independent signaling pathway.Ticagrelor breaks up the tumor-platelet party.The Role of Platelet-Derived ADP and ATP in Promoting Pancreatic Cancer Cell Survival and Gemcitabine Resistance.Carpe low-dose aspirin: the new anti-cancer face of an old anti-platelet drug.The Predictive Value of Inflammation-Related Peripheral Blood Measurements in Cancer Staging and Prognosis.A Temporal Examination of Platelet Counts as a Predictor of Prognosis in Lung, Prostate, and Colon Cancer Patients.Mean platelet volume predicts survival in pancreatic cancer patients with synchronous liver metastases.Platelet Metabolism and Other Targeted Drugs; Potential Impact on Immunotherapy.Low-Dose Aspirin and Pancreatic Cancer Risk-Reply.Evidence-based complementary treatment of pancreatic cancer: a review of adjunct therapies including paricalcitol, hydroxychloroquine, intravenous vitamin C, statins, metformin, curcumin, and aspirin
P2860
Q33657469-26511AE3-E123-4378-91E9-473AB60CF77AQ33728292-E47785A3-01CB-4C48-A76C-1782C89F1B1CQ38668187-2D6AC7C9-4FC2-4B8A-BF0C-D211B521DF45Q39408199-02D07611-7BD0-4331-BD43-0E1D761F24A6Q39434447-C472F65A-DF72-4709-92AA-35949ECD3921Q39454244-E144A1DC-24BD-4C3D-A745-F04DFF20E404Q41420993-87A41366-3588-485D-AF57-730EE6DE17D4Q41472852-397972E7-9751-422E-936D-8F98BAD992EEQ42361186-C8CDB3B4-FDB4-4E12-AA24-5FF110E2EE2CQ42991719-8CDD451D-F57F-46A9-88E0-170C10DBBA90Q47229243-DFE60A8A-D6F0-43E3-826F-4E077E9427ABQ52605888-BF024FB2-ABB2-4D14-A1EA-4E45F12996FDQ54936867-FB3DBFEA-CEB8-4042-88E7-16D0B38D453FQ55228708-C592A3D1-20DB-4835-95D0-0A413467B898Q55398181-165477F8-483D-4D4B-B6F5-E19BF2A8DE31Q55440587-C475CA4F-6BFE-4B55-B778-A441DCDE7905Q57176118-802AB9C9-4366-44FD-8C6E-3C32B22808C6
P2860
Aspirin therapy reduces the ability of platelets to promote colon and pancreatic cancer cell proliferation: Implications for the oncoprotein c-MYC.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Aspirin therapy reduces the ab ...... ons for the oncoprotein c-MYC.
@en
type
label
Aspirin therapy reduces the ab ...... ons for the oncoprotein c-MYC.
@en
prefLabel
Aspirin therapy reduces the ab ...... ons for the oncoprotein c-MYC.
@en
P2093
P2860
P1476
Aspirin therapy reduces the ab ...... ons for the oncoprotein c-MYC.
@en
P2093
Anh T P Ngo
Annachiara Mitrugno
Craig D Williams
Jiaqing Pang
Joanna L Sylman
Owen J T McCarty
Rosalie C Sears
P2860
P304
P356
10.1152/AJPCELL.00196.2016
P577
2016-11-30T00:00:00Z